PacificGMP Increases Production Capacity - - BioPharm International

ADVERTISEMENT

PacificGMP Increases Production Capacity



PacificGMP, a CMO, has doubled its GMP production capacity with the addition of a second System 1000 Bioreactor platform from GE Healthcare. This second System 1000, with a 500 L working volume, increases PacificGMP’s large scale GMP production capacity to 1000 L for fed and fed-batch production. In addition, it provides an additional 15,000 L of production capacity when run in perfusion mode. The addition provides PacificGMP a total perfusion capacity of 30,000 L.

Expansion of its operational capacity will allow PacificGMP to increase its large scale clinical manufacturing projects for its research clients, customers, and partners.

Source: PacificGMP

blog comments powered by Disqus

ADVERTISEMENT

ADVERTISEMENT

FDA Extends Review of Novartis' Investigational Compound for Multiple Myeloma
November 25, 2014
Merck Enters into Licensing Agreement with NewLink for Investigational Ebola Vaccine
November 25, 2014
AstraZeneca Expands Biologics Manufacturing in Maryland
November 25, 2014
GSK Leads Big Pharma in Making Its Medicines Accessible
November 24, 2014
IMS: Global Spending on Medicines to Rise 30% by 2018
November 24, 2014
Author Guidelines

Click here